Oric Pharmaceuticals, Inc. — Director's Dealing 2020

Apr 24, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Oric Pharmaceuticals, Inc. (ORIC)
CIK: 0001796280
Period of Report: 2020-04-23

Reporting Person: Multani Pratik S (Chief Business Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$1.60	2028-09-19	Common Stock (231250)		Direct

Footnotes

F1: The option is subject to an early exercise provision and is immediately exercisable. One fourth (1/4th) of the shares subject to the option vested on September 17, 2019, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.